Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

67053 1513184208HCLSReviewBulgariaDecember2017.pdf
Energy Boardroom

DSP commits to cell therapy, regen medicine as R&D pillar

06.03.2014 / Scripintelligence

Dainippon Sumitomo Pharma (DSP) has signaled its intention to position cell therapy and regenerative medicine, along with vaccines, as a major new pillar of its R&D strategy, in parallel with a continued focus on the firm's main strategic areas of…

LATEST ISSUE

DOWNLOAD

Most Read

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: